[Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004338:Drug Combinations; D004295:Dihydroxyphenylalanine
Trattamento del morbo di Parkinson con L-dopa e con una associazione de L-dopa inibitore della dopa-decarbossilasi.